Company / PP&E (Net)
ANAPTYSBIO, INC PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$1.4M
FY2025
5-year range
$1.4M / $2.3M
FY2021-FY2025
Trend
-25.9%
vs FY2024
Sector context
#146 of 193
Health Care
What the data says
ANAPTYSBIO, INC's pp&e (net) of $1M is lower than 76% of companies in the Health Care sector (FY2025). PP&E (Net) has fluctuated over the past 10 years, ranging from $471,000 in FY2016 to $2M in FY2021.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of -5.1%.
Declined from $2M to $1M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -13.1%
- 5-Year CAGR
- -5.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 193This company $1.4M Sector average $777.6M
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -5.1%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 25.9% year-over-year.
- Ranks #146 out of 193 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4M | -25.9% |
| FY2024 | $1.8M | -11.9% |
| FY2023 | $2.1M | +0.4% |
| FY2022 | $2.1M | -8.5% |
| FY2021 | $2.3M | +28.0% |
| FY2020 | $1.8M | +10.2% |
| FY2019 | $1.6M | +12.0% |
| FY2018 | $1.4M | +117.3% |
| FY2017 | $665.0K | +41.2% |
| FY2016 | $471.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026